My Quote Request
No products added yet
6505-01-077-6111
20 Products
NDC10038-0031-07 AMBIX LABS DIV.
HYDROCORTISONE OINTMENT,USP
NSN, MFG P/N
6505010776111
NSN
6505-01-077-6111
NDC10038-0031-07 AMBIX LABS DIV.
HYDROCORTISONE OINTMENT,USP
NSN, MFG P/N
6505010776111
NSN
6505-01-077-6111
MFG
U S DEPT OF VETERANS AFFAIRS
Description
ACTIVE INGREDIENT AND STRENGTH: 1.000 HYDROCORTISONE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: MEDICAMENT BASE TYPE:EMOLLIENT
Related Searches:
314
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010768378
NSN
6505-01-076-8378
314
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010768378
NSN
6505-01-076-8378
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 97.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ENEMA
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 14.000 OUNCES
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH 72 INCHES OF TUBING,5/16 INCH LUMEN,PLASTIC SPRING CLAMP,AND RIGID TIP; TOP FILL,SNAP CAP
Related Searches:
F91F061
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010768378
NSN
6505-01-076-8378
F91F061
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010768378
NSN
6505-01-076-8378
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 97.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ENEMA
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 14.000 OUNCES
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH 72 INCHES OF TUBING,5/16 INCH LUMEN,PLASTIC SPRING CLAMP,AND RIGID TIP; TOP FILL,SNAP CAP
Related Searches:
SOL-O-PAK
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010768378
NSN
6505-01-076-8378
SOL-O-PAK
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010768378
NSN
6505-01-076-8378
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 97.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ENEMA
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 14.000 OUNCES
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH 72 INCHES OF TUBING,5/16 INCH LUMEN,PLASTIC SPRING CLAMP,AND RIGID TIP; TOP FILL,SNAP CAP
Related Searches:
GAVISCON TABLETS
ALUMINA AND MAGNESI
NSN, MFG P/N
6505010768381
NSN
6505-01-076-8381
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 80MG ALUMINUM HYDROXIDE ACTIVE INGREDIENT; 20MG MAGNESIUM TRISILICATE ACTIVE INGREDIENT; STRIP; W/ALGINIC ACID AND SODIUM BICARBONATE; 2 TABLETS PER PACKET; 15 FOIL PACKETS PER PACKAGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM HYDROXIDE GEL DRIED & MAGNESIUM TRISILICATE TABLETS 30S
Related Searches:
NDC00088-1175-30
ALUMINA AND MAGNESI
NSN, MFG P/N
6505010768381
NSN
6505-01-076-8381
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 80MG ALUMINUM HYDROXIDE ACTIVE INGREDIENT; 20MG MAGNESIUM TRISILICATE ACTIVE INGREDIENT; STRIP; W/ALGINIC ACID AND SODIUM BICARBONATE; 2 TABLETS PER PACKET; 15 FOIL PACKETS PER PACKAGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM HYDROXIDE GEL DRIED & MAGNESIUM TRISILICATE TABLETS 30S
Related Searches:
NDC00045-0095-69
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010772780
NSN
6505-01-077-2780
NDC00045-0095-69
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010772780
NSN
6505-01-077-2780
MFG
MCNEIL PHARMACEUTICAL CO
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.270 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.003 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.08 POUNDS
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES USP 250S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20000 USP UNITS AMYLASE,4000 USP UNITS LIPASE,AND 25000 USP UNITS PROTEASE
SUPPLEMENTARY FEATURES: SOLE SOURCE ITEM FOR DOD, PANCREASE BY MCNEIL
Related Searches:
PANCREASE
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010772780
NSN
6505-01-077-2780
PANCREASE
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010772780
NSN
6505-01-077-2780
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.270 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.003 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.08 POUNDS
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES USP 250S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20000 USP UNITS AMYLASE,4000 USP UNITS LIPASE,AND 25000 USP UNITS PROTEASE
SUPPLEMENTARY FEATURES: SOLE SOURCE ITEM FOR DOD, PANCREASE BY MCNEIL
Related Searches:
PANCREASE CAPSULES
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010772780
NSN
6505-01-077-2780
PANCREASE CAPSULES
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010772780
NSN
6505-01-077-2780
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.270 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.003 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.08 POUNDS
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES USP 250S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20000 USP UNITS AMYLASE,4000 USP UNITS LIPASE,AND 25000 USP UNITS PROTEASE
SUPPLEMENTARY FEATURES: SOLE SOURCE ITEM FOR DOD, PANCREASE BY MCNEIL
Related Searches:
71505
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010774905
NSN
6505-01-077-4905
71505
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010774905
NSN
6505-01-077-4905
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LIMBITROL 5-12.5
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010774905
NSN
6505-01-077-4905
LIMBITROL 5-12.5
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010774905
NSN
6505-01-077-4905
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00140-0070-14
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010774905
NSN
6505-01-077-4905
NDC00140-0070-14
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010774905
NSN
6505-01-077-4905
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00024-1535-02
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774952
NSN
6505-01-077-4952
NDC00024-1535-02
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774952
NSN
6505-01-077-4952
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/W HEXACHLOROPHENE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
PHISOHEX
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774952
NSN
6505-01-077-4952
PHISOHEX
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774952
NSN
6505-01-077-4952
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/W HEXACHLOROPHENE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
NDC00185-3992-16
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774953
NSN
6505-01-077-4953
NDC00185-3992-16
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774953
NSN
6505-01-077-4953
MFG
VITARINE CO INC THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/W HEXACHLOROPHENE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
NDC11538-2008-01
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774953
NSN
6505-01-077-4953
NDC11538-2008-01
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505010774953
NSN
6505-01-077-4953
MFG
WEST CHEMICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/W HEXACHLOROPHENE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
CYTOSAR-U
CYTARABINE,USP
NSN, MFG P/N
6505010775690
NSN
6505-01-077-5690
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500 MG CYTARABINE ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PACKAGED W/10 ML BT OF BACTERIOSTATIC WATER FOR INJECTION; NOTE: D
Related Searches:
NDC00009-3070-01
CYTARABINE,USP
NSN, MFG P/N
6505010775690
NSN
6505-01-077-5690
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500 MG CYTARABINE ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PACKAGED W/10 ML BT OF BACTERIOSTATIC WATER FOR INJECTION; NOTE: D
Related Searches:
HYTONE
HYDROCORTISONE OINTMENT,USP
NSN, MFG P/N
6505010776111
NSN
6505-01-077-6111
MFG
DERMIK LABORATORIES INC SUB OF RORER PHARMACEUTICAL CORP
Description
ACTIVE INGREDIENT AND STRENGTH: 1.000 HYDROCORTISONE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: MEDICAMENT BASE TYPE:EMOLLIENT
Related Searches:
NDC00066-0087-01
HYDROCORTISONE OINTMENT,USP
NSN, MFG P/N
6505010776111
NSN
6505-01-077-6111
NDC00066-0087-01
HYDROCORTISONE OINTMENT,USP
NSN, MFG P/N
6505010776111
NSN
6505-01-077-6111
MFG
DERMIK LABORATORIES INC SUB OF RORER PHARMACEUTICAL CORP
Description
ACTIVE INGREDIENT AND STRENGTH: 1.000 HYDROCORTISONE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: MEDICAMENT BASE TYPE:EMOLLIENT
